HCA, AKA high-content screening systems (HCS), address a range of research applications from basic science to drug discovery screening. The device is usually paired with analysis software. HCA identifies the phnotype or target reaction of small morecules, peptides, RNAi, drug cocktail or, anitbody.
Based on high-resolution microscopic images, high content analysis (HCA) enables researchers to detect cellular phenotypic changes at a molecular level, so the technology can be utilized as a powerful tool to study effects of physiologically active substances, such as compounds, siRNA, peptides and antibodies, on cultured cells, tissue samples and whole organisms, like zebrafish.
This report contains market size and forecasts of High-Content Analysis (HCA) System in global, including the following market information:
Global High-Content Analysis (HCA) System Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global High-Content Analysis (HCA) System Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five High-Content Analysis (HCA) System companies in 2021 (%)
The global High-Content Analysis (HCA) System market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Instruments Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of High-Content Analysis (HCA) System include Thermo Fisher Scientific, PerkinElmer, Cytiva (formerly GE Healthcare), Molecular Devices LLC, Yokogawa Electric, SPT Labtech, BD Bioscience, BioTek and Nexcelom and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the High-Content Analysis (HCA) System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global High-Content Analysis (HCA) System Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global High-Content Analysis (HCA) System Market Segment Percentages, by Type, 2021 (%)
Instruments
Informatics & Software
Automation Solution
Other
Global High-Content Analysis (HCA) System Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global High-Content Analysis (HCA) System Market Segment Percentages, by Application, 2021 (%)
Drug Discovery
Cell Behaviour or Differentiation
Mechanistic Studies
Safety/Toxicology
Global High-Content Analysis (HCA) System Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global High-Content Analysis (HCA) System Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies High-Content Analysis (HCA) System revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies High-Content Analysis (HCA) System revenues share in global market, 2021 (%)
Key companies High-Content Analysis (HCA) System sales in global market, 2017-2022 (Estimated), (K Units)
Key companies High-Content Analysis (HCA) System sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
PerkinElmer
Cytiva (formerly GE Healthcare)
Molecular Devices LLC
Yokogawa Electric
SPT Labtech
BD Bioscience
BioTek
Nexcelom
Charles River